|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.35 TWD | -1.33% |
|
+0.11% | -1.00% |
Medigen Biotechnology Corp. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was TWD 251.32 million compared to TWD 164.25 million a year ago.
Net loss was TWD 75.75 million compared to TWD 94.69 million a year ago. Basic loss per share from continuing operations was TWD 0.54 compared to TWD 0.68 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -1.00% | 192M | |
| +16.59% | 44.44B | |
| +41.02% | 39.84B | |
| -10.62% | 37.68B | |
| +29.92% | 31.46B | |
| -9.23% | 27.02B | |
| +12.34% | 26.29B | |
| +41.53% | 13.8B | |
| +31.49% | 12.46B | |
| -7.40% | 11.26B |
MEDIGEN BIOTECHNOLOGY CORP. 
